Pediatric Neuroblastoma Treatment Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type: 2017 VS 2022 VS 2030
1.2.2 Immunotherapy
1.2.3 Chemotherapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pediatric Neuroblastoma Treatment Market Share by Application: 2017 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Neuroblastoma Treatment Market Perspective (2017-2030)
2.2 Pediatric Neuroblastoma Treatment Growth Trends by Region
2.2.1 Pediatric Neuroblastoma Treatment Market Size by Region: 2017 VS 2022 VS 2030
2.2.2 Pediatric Neuroblastoma Treatment Historic Market Size by Region (2017-2023)
2.2.3 Pediatric Neuroblastoma Treatment Forecasted Market Size by Region (2023-2030)
2.3 Pediatric Neuroblastoma Treatment Market Dynamics
2.3.1 Pediatric Neuroblastoma Treatment Industry Trends
2.3.2 Pediatric Neuroblastoma Treatment Market Drivers
2.3.3 Pediatric Neuroblastoma Treatment Market Challenges
2.3.4 Pediatric Neuroblastoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue
3.1.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue (2017-2023)
3.1.2 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Players (2017-2023)
3.2 Global Pediatric Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Neuroblastoma Treatment Revenue
3.4 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio
3.4.1 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Neuroblastoma Treatment Revenue in 2022
3.5 Pediatric Neuroblastoma Treatment Key Players Head office and Area Served
3.6 Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
3.7 Date of Enter into Pediatric Neuroblastoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Neuroblastoma Treatment Breakdown Data by Type
4.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Type (2017-2023)
4.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2023-2030)
5 Pediatric Neuroblastoma Treatment Breakdown Data by Application
5.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Application (2017-2023)
5.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Pediatric Neuroblastoma Treatment Market Size (2017-2030)
6.2 North America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2023)
6.3 North America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Pediatric Neuroblastoma Treatment Market Size (2017-2030)
7.2 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2017-2023)
7.3 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size (2017-2030)
8.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Country (2017-2023)
8.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Pediatric Neuroblastoma Treatment Market Size (2017-2030)
9.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2023)
9.3 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size (2017-2030)
10.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2017-2023)
10.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 United Therapeutics
11.1.1 United Therapeutics Company Detail
11.1.2 United Therapeutics Business Overview
11.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Introduction
11.1.4 United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023)
11.1.5 United Therapeutics Recent Development
11.2 Apeiron Biologics
11.2.1 Apeiron Biologics Company Detail
11.2.2 Apeiron Biologics Business Overview
11.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Introduction
11.2.4 Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023)
11.2.5 Apeiron Biologics Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pediatric Neuroblastoma Treatment Introduction
11.3.4 Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023)
11.3.5 Pfizer Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Pediatric Neuroblastoma Treatment Introduction
11.4.4 Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023)
11.4.5 Bayer Recent Development
11.5 Baxter
11.5.1 Baxter Company Detail
11.5.2 Baxter Business Overview
11.5.3 Baxter Pediatric Neuroblastoma Treatment Introduction
11.5.4 Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023)
11.5.5 Baxter Recent Development
11.6 Cellectar Biosciences
11.6.1 Cellectar Biosciences Company Detail
11.6.2 Cellectar Biosciences Business Overview
11.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Introduction
11.6.4 Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023)
11.6.5 Cellectar Biosciences Recent Development
11.7 MacroGenics
11.7.1 MacroGenics Company Detail
11.7.2 MacroGenics Business Overview
11.7.3 MacroGenics Pediatric Neuroblastoma Treatment Introduction
11.7.4 MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023)
11.7.5 MacroGenics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2022 VS 2030
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Others
Table 5. Global Pediatric Neuroblastoma Treatment Market Size Growth by Application (US$ Million): 2017 VS 2022 VS 2030
Table 6. Global Pediatric Neuroblastoma Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2030
Table 7. Global Pediatric Neuroblastoma Treatment Market Size by Region (2017-2023) & (US$ Million)
Table 8. Global Pediatric Neuroblastoma Treatment Market Share by Region (2017-2023)
Table 9. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 10. Global Pediatric Neuroblastoma Treatment Market Share by Region (2023-2030)
Table 11. Pediatric Neuroblastoma Treatment Market Trends
Table 12. Pediatric Neuroblastoma Treatment Market Drivers
Table 13. Pediatric Neuroblastoma Treatment Market Challenges
Table 14. Pediatric Neuroblastoma Treatment Market Restraints
Table 15. Global Pediatric Neuroblastoma Treatment Revenue by Players (2017-2023) & (US$ Million)
Table 16. Global Pediatric Neuroblastoma Treatment Market Share by Players (2017-2023)
Table 17. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2022)
Table 18. Ranking of Global Top Pediatric Neuroblastoma Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Pediatric Neuroblastoma Treatment Revenue (CR5 and HHI) & (2017-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
Table 22. Date of Enter into Pediatric Neuroblastoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Neuroblastoma Treatment Market Size by Type (2017-2023) & (US$ Million)
Table 25. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2017-2023)
Table 26. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 27. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2023-2030)
Table 28. Global Pediatric Neuroblastoma Treatment Market Size by Application (2017-2023) & (US$ Million)
Table 29. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application (2017-2023)
Table 30. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 31. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application (2023-2030)
Table 32. North America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2023) & (US$ Million)
Table 33. North America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 34. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2017-2023) & (US$ Million)
Table 35. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 36. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2017-2023) & (US$ Million)
Table 37. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2023-2030) & (US$ Million)
Table 38. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2023) & (US$ Million)
Table 39. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 40. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2017-2023) & (US$ Million)
Table 41. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 42. United Therapeutics Company Detail
Table 43. United Therapeutics Business Overview
Table 44. United Therapeutics Pediatric Neuroblastoma Treatment Product
Table 45. United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023) & (US$ Million)
Table 46. United Therapeutics Recent Development
Table 47. Apeiron Biologics Company Detail
Table 48. Apeiron Biologics Business Overview
Table 49. Apeiron Biologics Pediatric Neuroblastoma Treatment Product
Table 50. Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023) & (US$ Million)
Table 51. Apeiron Biologics Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Pediatric Neuroblastoma Treatment Product
Table 55. Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Bayer Company Detail
Table 58. Bayer Business Overview
Table 59. Bayer Pediatric Neuroblastoma Treatment Product
Table 60. Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023) & (US$ Million)
Table 61. Bayer Recent Development
Table 62. Baxter Company Detail
Table 63. Baxter Business Overview
Table 64. Baxter Pediatric Neuroblastoma Treatment Product
Table 65. Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023) & (US$ Million)
Table 66. Baxter Recent Development
Table 67. Cellectar Biosciences Company Detail
Table 68. Cellectar Biosciences Business Overview
Table 69. Cellectar Biosciences Pediatric Neuroblastoma Treatment Product
Table 70. Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023) & (US$ Million)
Table 71. Cellectar Biosciences Recent Development
Table 72. MacroGenics Company Detail
Table 73. MacroGenics Business Overview
Table 74. MacroGenics Pediatric Neuroblastoma Treatment Product
Table 75. MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2023) & (US$ Million)
Table 76. MacroGenics Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Neuroblastoma Treatment Market Share by Type: 2022 VS 2030
Figure 2. Immunotherapy Features
Figure 3. Chemotherapy Features
Figure 4. Others Features
Figure 5. Global Pediatric Neuroblastoma Treatment Market Share by Application in 2022 & 2030
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Pediatric Neuroblastoma Treatment Report Years Considered
Figure 10. Global Pediatric Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2017-2030
Figure 11. Global Pediatric Neuroblastoma Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2030
Figure 12. Global Pediatric Neuroblastoma Treatment Market Share by Region: 2022 VS 2030
Figure 13. Global Pediatric Neuroblastoma Treatment Market Share by Players in 2022
Figure 14. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Pediatric Neuroblastoma Treatment Revenue in 2022
Figure 16. North America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 17. North America Pediatric Neuroblastoma Treatment Market Share by Country (2017-2030)
Figure 18. United States Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 19. Canada Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 20. Europe Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 21. Europe Pediatric Neuroblastoma Treatment Market Share by Country (2017-2030)
Figure 22. Germany Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 23. France Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 24. U.K. Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 25. Italy Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 26. Russia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 27. Nordic Countries Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 28. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 29. Asia-Pacific Pediatric Neuroblastoma Treatment Market Share by Region (2017-2030)
Figure 30. China Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 31. Japan Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 32. South Korea Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 33. Southeast Asia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 34. India Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 35. Australia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 36. Latin America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 37. Latin America Pediatric Neuroblastoma Treatment Market Share by Country (2017-2030)
Figure 38. Mexico Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 39. Brazil Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 40. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 41. Middle East & Africa Pediatric Neuroblastoma Treatment Market Share by Country (2017-2030)
Figure 42. Turkey Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 43. Saudi Arabia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 44. United Therapeutics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2023)
Figure 45. Apeiron Biologics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2023)
Figure 46. Pfizer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2023)
Figure 47. Bayer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2023)
Figure 48. Baxter Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2023)
Figure 49. Cellectar Biosciences Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2023)
Figure 50. MacroGenics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Industry Market Size
